Annweshan

Pune, India Founded: 2015 • Age: 11 yrs
Offers comprehensive solutions for biological assays and screening to test activity.
Annual revenue $1,273 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Annweshan

Annweshan is a company based in Pune (India) founded in 2015 by Dhiman Sarkar and Manikankana Sarkar Bandyopadhyay. It operates as a B2B. Annweshan operates in a competitive market with competitors including Anabios, Metrion Biosciences, Antibody Analytics, Quiver Bioscience and Zen-Bio, among others.

  • Headquarter Pune, India
  • Founders Dhiman Sarkar, Manikankana Sarkar Bandyopadhyay
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Annweshan Scitech Private Limited
  • Date of Incorporation 13 Jan, 2015
  • Jurisdiction Pune, Maharashtra, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.27 K (USD)
    158.33
    as on Mar 31, 2020
  • Net Profit
    -$22.77 (USD)
    99.71
    as on Mar 31, 2020
  • EBITDA
    -$22.77 (USD)
    99.71
    as on Mar 31, 2020
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Annweshan

Premium access

Detailed funding history for Annweshan

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Annweshan

Investments
Premium access

Investment portfolio details for Annweshan

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Annweshan

Premium access

Detailed financials for Annweshan

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Annweshan Comparisons

Annweshan Primary company
Description
Offers comprehensive solutions for biological assays and scr...
Location
Pune, India
Founded Year
2015
Annual Revenue
$1.27 K (USD)
Net Profit
-$22.77 (USD)
EBITDA
-$22.77 (USD)
Employees
Not available
Premium access

Peer comparison for Annweshan

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Annweshan

Annweshan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Metrion Biosciences, Antibody Analytics, Quiver Bioscience and Zen-Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Ex-vivo human tissue studies are performed for preclinical drug discovery.
Locked Locked Locked
Ion channel screening and cardiac safety profiling services are provided.
Locked Locked Locked
Antibody analytics and characterization services are provided.
Locked Locked Locked
Developer of transformational medicines for neurological disorders
Locked Locked Locked
Cell-based solutions are provided to accelerate therapy discovery and development.
Locked Locked Locked
Drug-target interactions are quantified via specialized assay services.
Premium access

Detailed competitors of Annweshan

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Annweshan

Premium access

Complete news archive for Annweshan

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Annweshan

Annweshan was founded in 2015.

Annweshan is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Annual revenue of Annweshan is $1.27K as on Mar 31, 2020.

Annweshan, established in 2015, excels in providing healthcare solutions, advancing biotech innovations, biological assays, and screening protocols. Offers comprehensive solutions for biological assays and screening to test activity. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Annweshan's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available